2014
DOI: 10.1124/jpet.114.213520
|View full text |Cite
|
Sign up to set email alerts
|

Targeting the Myofibroblast Genetic Switch: Inhibitors of Myocardin-Related Transcription Factor/Serum Response Factor–Regulated Gene Transcription Prevent Fibrosis in a Murine Model of Skin Injury

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
97
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 92 publications
(101 citation statements)
references
References 40 publications
4
97
0
Order By: Relevance
“…The implication that MRTF-A activation drives fibrosis in the heart is complemented by work in other systems. Studies using the MRTF-A inhibitor developed in the Neubig laboratory demonstrated a role for MRTF-A in fibrosis associated with a bleomycin-induced skin injury (Haak et al, 2014). In this model, MRTF-A also mediates increases in a-SMA expression, which is consistent with its role in mediating a fibroblast to myofibroblast transition.…”
Section: Pathophysiological Consequences Of Gpcr-and Rhoa-mediated Trsupporting
confidence: 65%
See 1 more Smart Citation
“…The implication that MRTF-A activation drives fibrosis in the heart is complemented by work in other systems. Studies using the MRTF-A inhibitor developed in the Neubig laboratory demonstrated a role for MRTF-A in fibrosis associated with a bleomycin-induced skin injury (Haak et al, 2014). In this model, MRTF-A also mediates increases in a-SMA expression, which is consistent with its role in mediating a fibroblast to myofibroblast transition.…”
Section: Pathophysiological Consequences Of Gpcr-and Rhoa-mediated Trsupporting
confidence: 65%
“…Recent studies using LPA and the TCFindependent SRE luciferase construct to carry out chemical screens identified CCG-1423 [N-[2-[4(4-chlorophenyl)amino]-1-methyl-2-oxoethoxy]-3,5-bis(trifluoromethyl)-benzamide], a compound that potently and selectively inhibits MRTF-A signaling (Evelyn et al, 2007). This inhibitor and another subsequently identified inhibitor with higher potency have been used to block and thereby identify downstream MRTF-Amediated cellular responses (Haak et al, 2014;Zhao et al, 2014).…”
Section: Gpcr and Rhoa Regulation Of Mrtf-amentioning
confidence: 99%
“…At the same time, we examined three other genes, encoding alpha-smooth muscle actin (ACTA2), connective tissue growth factor (CTGF), and ankyrin repeat domain-containing protein 1 (ANKRD1), all of which are established MRTF-A-and YAP-regulated genes (7,31,(36)(37)(38)(39)(40). Knockdown of either YAP or MRTF-A fully abolished S1P-induced mRNA increases for all four of the genes (Fig.…”
Section: Resultsmentioning
confidence: 99%
“…Harnessing the natural regenerative capacity of epicardium-derived cardiovascular progenitor cells by modulating MRTF activity presents an exciting therapeutic strategy. Unlike most transcription factors, which are difficult to target pharmacologically, affecting MRTF localization and activity has proven feasible (Evelyn et al, 2007;Haak et al, 2014;Velasquez et al, 2013). It is interesting to speculate that epicardium-derived progenitor cells might be manipulated to promote neoangiogenesis and cardiac repair at the expense of fibroblast accumulation and scar formation.…”
Section: Discussionmentioning
confidence: 99%